Drug	Gene	Type	Source
sulindac	AKR1B1	IC50=0.374(uM)	D1 PubChem
sulindac	TDP1	Potency=11.8856(uM)	D1 PubChem
sulindac	CYP2C9	Potency=12.5893(uM)	D1 PubChem
sulindac	AHR	Potency=13.3332(uM)	D1 PubChem
sulindac	AHR	AhR Potency (uM)=16.5803(uM)	D1 PubChem
sulindac	AHR	AhR Potency (uM)=17.7801(uM)	D1 PubChem
sulindac	AHR	Potency=24.3365(uM)	D1 PubChem
sulindac	NFE2L2	Ratio Potency (uM)=29.4844(uM)	D1 PubChem
sulindac	RXRA	-	D1 PubChem
sulindac	CYP2C9	-	D1 PubChem
sulindac	PTGS2	-	D1 PubChem
sulindac	CYP3A4	-	D1 PubChem
sulindac	PTGS1	-	D1 PubChem
sulindac	CYP1A2	-	D1 PubChem
sulindac	CYP2C19	-	D1 PubChem
sulindac	CYP2D6	-	D1 PubChem
sulindac	EHMT2	Potency=50118.7(nM)	D1 ChEMBL
sulindac	CYP1A2	AC50=12589.2(nM)	D1 ChEMBL
sulindac	CYP2C19	Inhibition=None(Unspecified)	D1 ChEMBL
sulindac	CYP3A4	Inhibition=None(Unspecified)	D1 ChEMBL
sulindac	CYP2D6	Inhibition=None(Unspecified)	D1 ChEMBL
sulindac	CYP2C9	Inhibition=None(Unspecified)	D1 ChEMBL
sulindac	CYP1A2	Inhibition=None(Unspecified)	D1 ChEMBL
sulindac	CYP1A2	AC50=3981.07(nM)	D1 ChEMBL
sulindac	EHMT2	Potency=8436.8(nM)	D1 ChEMBL
sulindac	KDM4E	Potency=35481.3(nM)	D1 ChEMBL
sulindac	CYP2C9	Potency=12589.3(nM)	D1 ChEMBL
sulindac	CYP2C9	AC50=12589.2(nM)	D1 ChEMBL
sulindac	RXRA	Inhibition=None(Unspecified)	D1 ChEMBL